Related Experiment Video
Updated: Nov 6, 2025

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
SPARC promotes pancreatic cancer cell proliferation and migration through autocrine secretion into the extracellular
Kehua Pan1, Xince Huang2, Xiufen Jia1
1Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.
Abstract:
SPARC is a secreted glycoprotein that plays a complex and multifaceted role in tumour formation and progression. However, whether SPARC is an oncogene or a tumour suppressor is still unclear. Moreover, SPARC demonstrates potential in clinical pancreatic adenocarcinoma (PAAD) treatment, although it has been identified as an oncogene in some studies and a tumor suppressor in others. In the present study, a pan-cancer analysis of SPARC was carried out using The Cancer genome Atlas data, which demonstrated that SPARC was an oncogene in most cancer types and a cancer suppressor in others. In addition, SPARC expression was significantly upregulated in PAAD and associated with poor prognosis. SPARC also promoted the proliferation and migration of PANC-1 and SW1990 cell lines in vitro. SPARC was detected in the culture supernatant of PAAD cells and pancreatic acinar AR42J cells. SPARC regulated PAAD cell proliferation only when secreted into the extracellular milieu, thus explaining why the prognosis of patients with PAAD is correlated with the SPARC expression of both tumour cells and stromal cells. Collectively, the present findings demonstrated that the function of SPARC was associated with tumour type and that SPARC may represent an important oncogene in PAAD that merits further study.
Insights
Secreted protein acidic and rich in cysteine (SPARC) acts as an oncogene in most cancers, including pancreatic adenocarcinoma (PAAD). SPARC promotes PAAD cell proliferation and migration, correlating with poor patient prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Secreted protein acidic and rich in cysteine (SPARC) has a complex role in tumor development, with conflicting evidence on its oncogenic or tumor-suppressive functions.
- SPARC's dual role necessitates further investigation, particularly in pancreatic adenocarcinoma (PAAD), where its therapeutic potential is being explored.
Purpose of the Study:
- To conduct a pan-cancer analysis of SPARC expression and function.
- To investigate the specific role of SPARC in pancreatic adenocarcinoma (PAAD) pathogenesis and its association with patient prognosis.
Main Methods:
- Pan-cancer analysis utilizing The Cancer Genome Atlas (TCGA) data.
- In vitro experiments assessing the impact of SPARC on PAAD cell proliferation and migration (PANC-1 and SW1990 cell lines).
- Detection of SPARC in cell culture supernatants.
Main Results:
- SPARC functions as an oncogene in most cancer types but as a tumor suppressor in others.
- SPARC expression is significantly upregulated in PAAD and linked to poorer patient outcomes.
- SPARC enhances PAAD cell proliferation and migration in vitro, particularly when secreted extracellularly.
Conclusions:
- SPARC's role is context-dependent, varying with tumor type.
- SPARC acts as a significant oncogene in pancreatic adenocarcinoma (PAAD).
- SPARC's extracellular function in PAAD highlights its importance in tumor progression and suggests potential as a therapeutic target.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Cancer Cell Migration through Invadopodia

